Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Dermacyd PH_DETINLYN · 3 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Dermacyd PH\_DETINLYN (Lactic Acid) |
| Name | Type | Description |
|---|---|---|
| Dermacyd PH_DETINLYN (Lactic Acid) | DRUG | - |
Inclusion criteria: * Phototype Skin II and III; * Integral skin test in the region; * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion; Exclusion criteria: * Lactation or gestatio...
Dermacyd PH_DETINLYN is a small molecule product used for hygiene purposes. It is being developed by Sanofi (ticker: SNY) and is currently in Phase 3 clinical development. The product contains lactic acid and is intended for use in hygiene applications, as studied in clinical trials.
Dermacyd PH_DETINLYN is developed by Sanofi, a multinational pharmaceutical company listed on the stock exchange under the ticker SNY. Sanofi is conducting clinical trials for this hygiene product, which is currently in Phase 3 development.
Dermacyd PH_DETINLYN is in Phase 3 clinical development. It is an investigational product and has not been approved by regulatory authorities. The Phase 3 trials have been completed, and the product is being studied for hygiene applications.
Dermacyd PH_DETINLYN has been studied in three completed Phase 3 clinical trials: NCT00785590, NCT00785655, and NCT00786097. These trials evaluated the product's photo evaluation and compatibility in healthy female volunteers aged 18 years and older in Brazil.
Dermacyd PH_DETINLYN is not FDA approved. It is an investigational product currently in Phase 3 clinical development. The completed trials have been conducted in Brazil, and the product has not received regulatory approval in the United States or elsewhere.
Dermacyd PH_DETINLYN contains lactic acid as its active ingredient. It is a small molecule product developed for hygiene purposes. The clinical trials evaluated the product's compatibility and photo evaluation in healthy female volunteers.